Burden grows for individuals, families, and governments as agencies raise warning
The recent World Alzheimer Report for 2010 [opens to PDF] says that the societal cost of dementia is not only already enormous, but that dementia is also significantly affecting every health and social care system in the world. Additionally, the economic impact on families is insufficiently appreciated. More ominously, the report predicts that worldwide, the costs of dementia are set to soar. And it states there is an urgent need to develop cost-effective packages of medical and social care that meet the needs of people with dementia and their caregivers across the course of the illness, and evidence-based prevention strategies. (more…)
The Canadian Psychiatric Association recently issued its first 
Police 
Two of Clem Martini’s brothers have been diagnosed with schizophrenia. One is Ben, the youngest. The other is Olivier, or Liv, an artist. Olivier illustrates this graphic memoir with a subtle hand…his side in a long conversation, spanning some 30 years, with his brother Clem, a Calgary playwright.
The late Dr. Abram Hoffer MD, PhD, was a Canadian orthomolecular psychiatrist and researcher. Dr. Hoffer and his co-workers were instrumental in the discovery that megadoses of vitamin B3 (nicotinic acid/niacin) were therapeutic for schizophrenia and can be used to lower cholesterol levels. The discovery, which was published in 1955, is credited with the initiation of a new paradigm in nutritional medicine—the use of vitamins for treatment and not just for prevention of disease. 